Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-23-008557
Filing Date
2023-11-30
Accepted
2023-11-29 21:35:37
Documents
70
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR AUG 2023 cnbx_i10k-083123.htm   iXBRL 10-K 923105
2 CERTIFICATION cnbx_ex3101.htm EX-31.1 11253
3 CERTIFICATION cnbx_ex3102.htm EX-31.2 11377
4 CERTIFICATION cnbx_ex3201.htm EX-32.1 4303
5 CERTIFICATION cnbx_ex3202.htm EX-32.2 4435
6 GRAPHIC image_001.jpg GRAPHIC 26380
7 GRAPHIC image_002.jpg GRAPHIC 31410
8 GRAPHIC image_009.jpg GRAPHIC 6798
9 GRAPHIC image_010.jpg GRAPHIC 53964
10 GRAPHIC image_011.jpg GRAPHIC 10414
11 GRAPHIC image_012.jpg GRAPHIC 34293
12 GRAPHIC image_013.jpg GRAPHIC 2614
13 GRAPHIC image_014.jpg GRAPHIC 4766
14 GRAPHIC image_015.jpg GRAPHIC 27082
15 GRAPHIC image_016.jpg GRAPHIC 14976
16 GRAPHIC image_017.jpg GRAPHIC 67011
17 GRAPHIC image_018.jpg GRAPHIC 40033
18 GRAPHIC image_019.jpg GRAPHIC 46207
19 GRAPHIC image_019.gif GRAPHIC 15103
  Complete submission text file 0001683168-23-008557.txt   4627012

Data Files

Seq Description Document Type Size
20 XBRL SCHEMA FILE cnbx-20230831.xsd EX-101.SCH 28725
21 XBRL CALCULATION FILE cnbx-20230831_cal.xml EX-101.CAL 35822
22 XBRL DEFINITION FILE cnbx-20230831_def.xml EX-101.DEF 92600
23 XBRL LABEL FILE cnbx-20230831_lab.xml EX-101.LAB 205184
24 XBRL PRESENTATION FILE cnbx-20230831_pre.xml EX-101.PRE 175475
64 EXTRACTED XBRL INSTANCE DOCUMENT cnbx_i10k-083123_htm.xml XML 370351
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 231453820
SIC: 2834 Pharmaceutical Preparations